Sign Up to like & get
recommendations!
0
Published in 2021 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202108_26547
Abstract: OBJECTIVE Remifentanil (RF) is a potent short-acting μ-opioid receptor agonist. Although preferred for its unique pharmacokinetics, the clinical use may be limited by hyperalgesia. Preclinical studies have shown a potential role of microglia on the…
read more here.
Keywords:
remifentanil human;
c20 microglial;
human c20;
pro inflammatory ... See more keywords